December 27, 2016 5:22pm
The downside after the morning’s upside became the afternoon’s glide path
The stem, cell, gene and regenerative therapy (SCG&RT) sector opened positive, stayed positive at the mid-day and closed positive.
Pre-open indication’s tally: 1 hits (ONVO) and 2 miss (BLCM and VSTM)
Can you afford to miss the insider view in 2017 … subscribe to translate news and interpret sentiment in the stem, cell and gene and regenerative therapy (SCGT&RT) universe layered with a current pricing metric ...
Click here for access and subscribe: http://www.regmedinvestors.com/create-account
I answer one question; in which company should investors put, keep and commit their money!
U.S. stocks ended slightly higher Tuesday, kicking off the last trading week of the year on a positive note with the NASDAQ setting a closing record.
The NASDAQ closed UP +24.75 or +0.45% to 5,487.44 and the DOW closed UP +11.23 or +0.06% to 19,945.04.
A day in the life of the stem, cell, gene and regenerative therapy (SCGT & RT) sector – the advance/decline line scenario of our 43 covered companies:
- The open was positive with an A/DL of 28/11 and 4 flats;
- The mid-day stayed positive with an A/DL of 22/16 and 3 flats;
- The closing bell slipped negative with A/DL of 18/24 and 1 flat;
Henry’omics:
The stem, cell, gene and regenerative therapy (SCG&RT) sector opened positive, stayed positive at the mid-day and closed negative.
- The iShares Nasdaq Biotechnology ETF (IBB) erased early but, minimal gains to close -0.39% lower.
From this morning’s investor’s letter, “I believe Q1 is still a reflection of 2016 until Q4/16 results are released and only then will the chains and shackles of 2016 be cut! Companies will be better served by saving ANY big news or events until afterQ4/16 are released.”
- Today’s sessions did nothing to improve the fortunes of sector stocks. They sold into strength, slipping in and out of favor due to the continuous issue of pricing risk amid trading and momentum rotations.
The iShares Russell 2000 (IWM) indicated a negative -0.01% in the pre- open and closed UP +0.45%; the iShares NASDAQ Biotechnology (IBB) indicated a positive +0.25% in the pre-open and closed DOWN -0.39%.
- The CBOE Volatility Index (VIX), widely considered the best gauge of fear in the market, traded lower near 12.
Today’s 3 biggest $ gainers included:
- Vericel (VCEL) +$0.30;
- Asterias Biotherapeutics (NYSEMKT: AST) +$0.25;
- Aduro Biotech (ADRO) +$0.25;
Today’s 3 biggest $ losers of the session were:
- Northwest Bio (NWBO) -$0.22;
- Regenxbio (RGNX) -$0.20;
- Cellectis SA (CLLS) -$0.19
The downside trend reflects a pricing trend range of:
- Tuesday’s decliners ranged from -0.29% <RENE.L> to -38.96% <NWBO>in 24 equities;
- Monday was a holiday;
- Friday’s decliners ranged from -0.58% <AXGN>to -13.91 <ISCO>in 7 equities;
- Thursday’s decliners ranged from -0.39% <KOOL> to -10.71% <SGMO> in 30 equities;
- Wednesday’s decliners ranged from – 0.20% <MESO> to –7.22% <KOOL) in 31 equities;
- Last Tuesday’s decliners ranged from -0.32% <CUR> to -28.35% <NWBO> in 15 equities;
The upside shows a pricing trend range of:
- Tuesday gainers ranged from +0.31% <BLUE> to +11.21% <ISCO> in 18 equities;
- Monday was a holiday;
- Friday gainers ranged from +0.58% <NWBO>to +9.45% <ADRO> in 34 equities;
- Thursday’s gainers ranged from +0.36% <FATE> to +39.31% <NWBO> in 10 equities;
- Wednesday’s gainers ranged from +0.28% <VTGN> to +1.68% <CAPR> in 9 equities;
- Last Tuesday’s gainers ranged from +0.07% <BLUE> to +9.52 <ADVM>in 25 equities;
Wrap-up: anybody can read a paragraph … review the percentage changes per day in the week of the decliners and advancers while …
- Tuesday’s 18 gainers followed Monday’s holiday as compared to Friday’s 34
- Tuesday’s x24 decliners followed Monday’s holiday as compared to Friday’s 7
Pre-open indication’s tally: 1 hits (ONVO) and 2 miss (BLCM and VSTM)
- Bellicum Pharmaceuticals (BLCM) closed DOWN -$0.11 – miss;
- Organovo (ONVO) closed UP +$0.06 – hit;
- Verastem (VSTM) closed DOWN -$0.02 – miss;
Percentage (%) decliners:
- Northwest Bio (NWBO) -38.96%;
- VistaGen (VTGN) -0.80%;
- Biostage (BSTG) -3.25%;
- Sangamo (SGMO) -3.23%;
- Fibrocell (FCSC) -2.87% after Friday’s -8%
Percentage (%) advancers:
- International Stem Cell (ISCO) +11.21% after Friday’s -13.91%;
- Vericel (VCEL) +10.53% after Friday’s -1.72%;
- Opexa (OPXA) +6.25%;
- Cesca Therapeutics (KOOL) +6.35%;
- Asterias Biotherapeutics (NYSEMKT: AST) +5.43%
Flat:
- Pluristem (PSTI) at $1.52;
Review my fear gauge or the CBOE Volatility Index (VIX):
· Tuesday traded near 12;
· Monday was a holiday;
· Friday traded near 11.6;
· Thursday traded near 11.5;
· Wednesday traded near 11.3;
· Last Tuesday traded near 11.5;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
